Hauptkonkurrenten
Dividendenrendite (Y) Dividendenrendite (Y+1) KGV (Y) Price to Book (Y) EV / Sales (Y) Marktkap. / EBITDA (Y) Marktkap. / EBIT (Y) Kap.($)
- - - - - - - 21,33 Mio.
0,75 %0,83 %26.9x16.59x10.08x20.2x21.96x 809 Mrd.
2,27 %2,37 %25.14x6.31x5.78x15.69x17.38x 565 Mrd.
3,31 %3,45 %23.52x140x6.29x12.77x13.13x 370 Mrd.
1,65 %1,75 %25.36x5.59x5.24x14.79x15.64x 312 Mrd.
2,93 %3,02 %27.32x5.07x4.77x14.81x17.56x 285 Mrd.
2,95 %3,08 %20.77x6.27x5.58x13.5x14.76x 286 Mrd.
2,88 %3,08 %23.43x16.7x6.05x10.71x13.74x 189 Mrd.
4,19 %4,36 %12.28x5.16x4.38x9.16x10.77x 180 Mrd.
2,34 %2,39 %18.81x6.22x5.88x10.82x12.72x 172 Mrd.
6,44 %6,42 %12.34x1.75x3.27x7.88x9.23x 155 Mrd.
4,29 %4,41 %12.02x5.11x3.15x8.3x9.09x 120 Mrd.
5,26 %5,6 %11.83x1.26x2.32x7.46x8.2x 115 Mrd.
3,29 %3,57 %13.43x4.4x2.85x8.27x9.42x 115 Mrd.
-.--%-.--%24.89x4.92x7.5x16.9x17.47x 111 Mrd.
1,59 %1,77 %27.92x6.23x9.55x17.95x18.77x 88,83 Mrd.
3,54 %3,6 %50.53x1.25x2.84x10.48x29.74x 56,04 Mrd.
0,47 %0,54 %40.9x5.5x9.29x31.05x33.9x 55,87 Mrd.
Durchschnitt 2,83 % 2,96 % 23,38x 14,02x 5,58x 13,57x 16,09x 221,28 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung 2,48 % 2,59 % 23,29x 20,56x 6,30x 14,55x 16,31x
Pharmazeutika - Andere